The Recall Desk
HighFDA (Devices)·Z-1484-2026·Announced 2026-03-11

Siemens urine albumin assay may report falsely depressed patient results

Siemens Healthcare Diagnostics is recalling all lots of the Atellica CH Urine Albumin assay because falsely depressed patient results may occur above the measuring interval.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Rubric level 3 covers risk-of-harm products where injury has not yet been reported: the assay can under-report patient results across the whole range above its measuring interval, and no injuries are stated in the source.

Plain-English summary

Siemens Healthcare Diagnostics, Inc. is recalling the Atellica CH Urine Albumin (UAlb) assay, material number 11537225. About 4,885 units were distributed worldwide, covering the United States nationwide and more than thirty other countries. The FDA has classified this recall as Class II.

Falsely depressed urine albumin patient results may occur. Affected samples with any urine albumin concentration above the measuring interval of 40.0 mg/dL may report values between 6.2 mg/dL and 40.0 mg/dL.

All lot numbers are affected. The product carries UDI-DI 00630414611099.

Laboratories can identify affected product by the material number and UDI above, and may contact Siemens Healthcare Diagnostics, Inc. for further information.

The recalled product

Product
Atellica CH Urine Albumin (UAlb). Material Number: 11537225
Affected units
4,885

Distribution

Distributed nationwide across the United States.

Same manufacturer · Siemens Healthcare Diagnostics, Inc.

See all →